trending Market Intelligence /marketintelligence/en/news-insights/trending/_brojezzflwkangslvwldq2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Novelion seeking approval for leptin drug in EU

Cable Nets For Kids Enjoy Wide Carriage On Skinny Bundles


Power Forecast Briefing: Fleet Transformation, Under-Powered Markets, and Green Energy in 2018

Street Talk Episode 50 - Challenging The Legacy Core Bank Providers

Fed Poised To Relax Key Rules For Large Banks

Novelion seeking approval for leptin drug in EU

Novelion Therapeutics Inc. is seeking approval for Metreleptin in Europe.

The company filed an application with the European Medicines Agency to market Metreleptin as therapy for leptin deficiency in patients with lipodystrophy, the loss of fat from a part of the body.

Metreleptin was orphan-drug designated in the EU in July 2012.